Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K
Gut-Brain Axis01:22

Gut-Brain Axis

122
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
122

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential Impacts of Components of Particulate Matter on Epithelial Cell Toxicity and Immune Responses.

ACS omega·2026
Same author

T-cell-targeted immunotherapy in neurofibromatosis type 2-related vestibular schwannoma: current evidence and future direction.

Brain communications·2026
Same author

Specific Deletion of Interleukin-1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke.

Glia·2026
Same author

Disruption of macrophage cell volume drives inflammatory responses and type I interferon signaling.

The Journal of cell biology·2026
Same author

A reciprocal glial circuit calibrates injury information and governs the tissue response balance.

Neuron·2026
Same author

Blocking microglial reactivity via purinergic receptors prevents subacute cognitive deficits after TIA.

EMBO molecular medicine·2026
Same journal

ALKBH4 Promotes Osteogenesis via Epigenetic Regulation of BMP2-Wnt/β-Catenin Signaling in Cervical Spine OPLL.

IUBMB life·2026
Same journal

Single-Sequence Deep Learning Delivers Crystal-Quality Models of Covalent K-Ras G12 Hotspot Complexes.

IUBMB life·2026
Same journal

Mechanism of PCSK9-Mediated Macrophage Activation via the CAP1/NF-κB Pathway in CAWS-Induced Kawasaki Disease Vasculitis.

IUBMB life·2026
Same journal

Hormesis and the Golden Ratio: Toward a Universal Estimator of Adaptive Capacity.

IUBMB life·2026
Same journal

MicroRNAs in HPV-Associated Carcinogenesis: Potential Biomarkers in Oropharyngeal and Cervical Cancers.

IUBMB life·2026
Same journal

PGAM1 Orchestrates Cell Cycle Progression, Glycolytic Reprogramming, and Immunosuppressive Microenvironment in Triple-Negative Breast Cancer.

IUBMB life·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

9.0K

Interleukin-1α and brain inflammation.

David Brough1, Adam Denes1,2

  • 1Faculty of Life Sciences, University of Manchester, Manchester, UK.

IUBMB Life
|April 25, 2015
PubMed
Summary
This summary is machine-generated.

Interleukin-1 alpha (IL-1α) is a key driver of inflammation following acute brain injuries. Targeting IL-1α pathways presents a promising new therapeutic strategy for stroke and other brain injuries.

Keywords:
Ca2+ signallingcell deathhuman molecular disease

More Related Videos

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K
Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
07:31

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Published on: August 23, 2022

4.1K

Related Experiment Videos

Last Updated: Apr 14, 2026

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

9.0K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K
Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
07:31

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Published on: August 23, 2022

4.1K

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Acute brain injuries, including stroke, are leading causes of death and disability.
  • Limited therapeutic options exist, necessitating novel treatment strategies.
  • Inflammation exacerbates brain injury and is a recognized therapeutic target.

Purpose of the Study:

  • To review the role of Interleukin-1 alpha (IL-1α) in acute brain injury.
  • To highlight IL-1α's regulation and contribution to brain damage.
  • To identify IL-1α processing and release mechanisms as potential therapeutic targets.

Main Methods:

  • Literature review focusing on IL-1α in acute brain injury.
  • Analysis of IL-1α's role in inflammation post-injury.
  • Examination of IL-1α regulation and release pathways.

Main Results:

  • IL-1α is an early and significant mediator of inflammation after acute brain injury.
  • While IL-1β has been studied, IL-1α's role is increasingly recognized.
  • Specific mechanisms regulating IL-1α processing and release are crucial.

Conclusions:

  • IL-1α plays a critical role in the inflammatory response following acute brain injury.
  • Targeting IL-1α presents a novel therapeutic avenue for treating acute brain injuries.
  • Further research into IL-1α regulation may yield effective treatments for stroke and other brain injuries.